Abstract:OBJECTIVES To clinically and histologically evaluate the efficacy of using acellular dermal matrix (ADM) for peri-implant vertical soft tissue augmentation at implant placement. MATERIALS AND METHODS Twenty patients were enrolled in this study. According to the initial thickness of vertical soft tissue, patients were assigned into the ADM group (≤2 mm) or the control group (>2 mm) prior to implant surgery + ADM grafting or implant surgery alone. Second-stage surgery was carried out 3 months later and a small piece of ridge membrane was harvested for histological and immunohistochemical evaluation. Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF)-BB in peri-implant crevicular fluid (PICF) were also assessed 1 week, 1 month and 5 months after second-stage surgery. Clinical parameters were recorded to evaluate peri-implant health at 1 week and 3 months after implant restoration. RESULTS All 20 implants healed uneventfully and successfully. Soft tissue thicknesses were comparable in the two groups at second-stage surgery (3.20 ± 0.42 mm vs 3.50 ± 0.58 mm). In the ADM group, the mean increase in soft tissue thickness was 1.85 ± 0.34 mm. Histological and immunohistochemical outcomes showed no differences between the two groups. VEGF and PDGF-BB levels in PICF were significantly lower in the ADM group 1 week after second-stage surgery (p < 0.01), yet they decreased in both groups later. The difference between the groups had disappeared by 5 months after second-stage surgery. The clinical peri-implant parameters were good and stable by the end of the study (3 months after restoration). CONCLUSIONS Our results suggested that using ADM at implant placement was effective in increasing the thickness of peri-implant vertical soft tissue and achieved comparable clinical and histological performance to the control group. However, the incremental soft tissue showed inferior angiogenic ability in the early stage of wound healing.

Application of acellular dermal matrix in open mastoidectomy

Application of Allogeneic Acellular Dermal Matrix (Allo-Adm) in Mastoidectomy

Clinical efficacy of acellular dermal matrix for plastic periodontal and implant surgery: a systematic review

Clinical Application of Heterogeneous Acellular Dermal Matrix with Autologous Bone Meal in Open Tympanoplasty

Repair Effect of Xenogeneic Acellular Dermal Matrix During External Auditory Canal Reconstruction after Canal Wall Down Mastoidectomy.

Clinical evaluation of repairing oral epithelial defects by acellular dermal matrix

Clinical observation of external canal reconstruction with autogenous bone pate in the micro-otosurgery

Clinical Application of Attic Reconstruction and Tympanoplasty for Operated Ears with Open Radical Mastoidectomy

Application of Autologous Bone Meal and Temporalis Fascia in Middle Ear and Mastoid Surgery

Acellular dermal matrix allograft to repair the defect of oral mucosa

Mastoid Obliteration with Occipital Myosubcutaneous Flap in Open Cavity Mastoidectomy

The Use of Human Acellular Dermal Matrix in the Prevention of Infra-Auricular Depressed Deformities and Frey's Syndrome Following Total Parotidectomy

[Heterogeneous acellular dermal matrix for wound repair after endoscopic Type-Ⅴa cordectomy]

Effectiveness of Acellular Dermal Matrix Prophylaxis in Mandibular Impacted Molars Extraction:A Meta-analysis

Clinical and Histological Evaluation of the Use of Acellular Dermal Matrix (ADM) Membrane in Peri-Implant Vertical Soft Tissue Augmentation: A Controlled Clinical Trial.

Clinical study of the infectd mastoid cavity after mastoidectomy

Modificatory Method of Management for the Open Mastoid Cavity and the Opening of External Acoustic Meatus

Application of Acellular Dermal Matrix in Reconstruction of Oral Mucosal Defects in 36 Cases.

Combined application of postauricular muculofascial flap with pedicle and tragus cartilage-perichondrium complex in open mastoidectomy

[Application of the Collagen in Mastoidectomy].

Using Autologous Mastoid Cortical Bone during Cochlear Implantation